MedCity News November 5, 2024
Katie Adams

Digital twin technology can serve as an effective complement to some of the exciting advancements occurring in the metabolic health space, such as new generations of continuous glucose monitors and a slew of GLP-1s, according to Lisa Shah, chief medical officer at Twin Health.

Over the past few years, the metabolic health space has been buzzing due to a mix of increasing awareness, novel drugs and personalized health tools. One of the most impactful developments in recent years has been the rise of GLP-1s like semaglutide and tirzepatide — with roughly 12% of Americans having taken a GLP-1 medication.

These drugs have garnered a lot of excitement — but they are not the sole solution to the country’s obesity and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Digital Health, Pharma / Biotech, Technology, Wearables
Related Articles:
How Digital Health Tools, AI, and Wearables are Transforming Care and Self-Management
Culina Health Snags $7.9M to Expand Access to Nutrition Care
ŌURA Promises Relentless Innovation As It Hits New Oura Ring Milestone
Digital Twins Aren’t Just for Big Businesses
How Did Digital Health Investors View This Year’s Funding Environment — and What Do They Predict for 2025?

Share This Article